Decreasing malaria prevalence and its potential consequences for immunity in pregnant women.

BACKGROUND As malaria control is intensified, pregnant women may be less exposed to malaria, thus affecting the acquisition of protective antibody. METHODS Plasma samples were collected from Malawian and Papua New Guinean (PNG) pregnant women enrolled over 7-year periods, during which malaria prevalence fell by over two thirds. Immunoglobulin G (IgG) levels to schizont extract, merozoite antigens, and VAR2CSA-DBL5ε were measured by enzyme-linked immunosorbent assay (ELISA). Levels of IgG to variant surface antigens of infected erythrocytes (IEs) and merozoites and levels of opsonizing IgG to IEs were measured by flow cytometry. RESULTS In both settings, levels of antibodies in pregnant women to recombinant antigens and to intact IEs but not of opsonizing antibodies decreased over time. After adjustment for coverage with insecticide-treated bed nets (ITNs), these differences disappeared in the Malawian cohort, whereas in the PNG cohort, time was independently associated with a decrease in several antibody responses measured by ELISA. CONCLUSIONS The impact of falling parasite prevalence on anti-Plasmodium falciparum serological indicators in pregnant women varies by setting. Increased ITN coverage may affect development of antibodies to recombinant antigens, but levels of opsonizing IgG remained stable over time. Opsonizing IgG against placental-binding IEs may persist, thus offering longer-lasting protection against malaria during pregnancy.

[1]  I. Adam,et al.  Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy. , 2014, The Journal of infectious diseases.

[2]  K. Bird,et al.  Improved economic conditions in Malawi: Progress from a low base , 2014 .

[3]  P. Siba,et al.  Opsonising Antibodies to P. falciparum Merozoites Associated with Immunity to Clinical Malaria , 2013, PloS one.

[4]  P. Alonso,et al.  High Antibody Responses against Plasmodium falciparum in Immigrants after Extended Periods of Interrupted Exposure to Malaria , 2013, PloS one.

[5]  Virander S. Chauhan,et al.  Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. , 2013, The Journal of infectious diseases.

[6]  J. Simpson,et al.  New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women , 2012, The Journal of infectious diseases.

[7]  T. Kulmala,et al.  Antibody to P. falciparum in Pregnancy Varies with Intermittent Preventive Treatment Regime and Bed Net Use , 2012, PloS one.

[8]  L. Hviid.  The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria , 2011, Expert review of vaccines.

[9]  M. Molyneux,et al.  Antibodies That Induce Phagocytosis of Malaria Infected Erythrocytes: Effect of HIV Infection and Correlation with Clinical Outcomes , 2011, PloS one.

[10]  T. Triglia,et al.  Evidence That the Erythrocyte Invasion Ligand PfRh2 is a Target of Protective Immunity against Plasmodium falciparum Malaria , 2010, The Journal of Immunology.

[11]  O. Lund,et al.  Insight into Antigenic Diversity of VAR2CSA-DBL5ε Domain from Multiple Plasmodium falciparum Placental Isolates , 2010, PLoS ONE.

[12]  A. Scherf,et al.  Strain-Transcendent Immune Response to Recombinant Var2CSA DBL5-ε Domain Block P. falciparum Adhesion to Placenta-Derived BeWo Cells under Flow Conditions , 2010, PloS one.

[13]  M. Molyneux,et al.  Decreasing Burden of Malaria in Pregnancy in Malawian Women and Its Relationship to Use of Intermittent Preventive Therapy or Bed Nets , 2010, PloS one.

[14]  Danny W. Wilson,et al.  Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development , 2010, Proceedings of the National Academy of Sciences.

[15]  Danny W. Wilson,et al.  Using an Improved Phagocytosis Assay to Evaluate the Effect of HIV on Specific Antibodies to Pregnancy-Associated Malaria , 2010, PloS one.

[16]  K. Maleta,et al.  Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment. , 2010, The Journal of infectious diseases.

[17]  Pierre Baldi,et al.  A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray , 2010, Proceedings of the National Academy of Sciences.

[18]  Joseph D. Smith,et al.  Immunization with VAR2CSA-DBL5 Recombinant Protein Elicits Broadly Cross-Reactive Antibodies to Placental Plasmodium falciparum-Infected Erythrocytes , 2010, Infection and Immunity.

[19]  S. Meshnick,et al.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. , 2009, The Journal of infectious diseases.

[20]  P. Gilson,et al.  Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness , 2009, Infection and Immunity.

[21]  T. Theander,et al.  VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. , 2008, The Journal of infectious diseases.

[22]  D. Conway,et al.  Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria , 2008, Infection and Immunity.

[23]  T. Theander,et al.  Differences in Human Antibody Reactivity to Plasmodium falciparum Variant Surface Antigens Are Dependent on Age and Malaria Transmission Intensity in Northeastern Tanzania , 2008, Infection and Immunity.

[24]  S. Cousens,et al.  Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? , 2008, Tropical medicine & international health : TM & IH.

[25]  D. Conway,et al.  Duration of Naturally Acquired Antibody Responses to Blood-Stage Plasmodium falciparum Is Age Dependent and Antigen Specific , 2008, Infection and Immunity.

[26]  A. Cowman,et al.  Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. , 2008, The Journal of clinical investigation.

[27]  D. Conway,et al.  IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life , 2007, Malaria Journal.

[28]  F. T. Ter Kuile,et al.  Epidemiology and burden of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[29]  Thor G. Theander,et al.  Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.

[30]  K. Marsh,et al.  Intermittent Preventive Sulfadoxine-Pyrimethamine Treatment of Primigravidae Reduces Levels of Plasma Immunoglobulin G, Which Protects against Pregnancy-Associated Plasmodium falciparum Malaria , 2004, Infection and Immunity.

[31]  M. Molyneux,et al.  Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection , 2004, The Lancet.

[32]  E. J. Mann,et al.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. , 2004, The Journal of infectious diseases.

[33]  Kevin Marsh,et al.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria , 2004, The Lancet.

[34]  M. Fried,et al.  Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.

[35]  R. Leke,et al.  Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.

[36]  J. Reeder,et al.  Parasite adhesion and immune evasion in placental malaria. , 2001, Trends in parasitology.

[37]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[38]  M. Molyneux,et al.  Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. , 1999, The Journal of infectious diseases.

[39]  T. Theander,et al.  A Longitudinal Study of Human Antibody Responses toPlasmodium falciparum Rhoptry-Associated Protein 1 in a Region of Seasonal and Unstable Malaria Transmission , 1999, Infection and Immunity.

[40]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[41]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[42]  Shigeru Tsuchiya,et al.  Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1) , 1980, International journal of cancer.

[43]  F. Nosten,et al.  Malaria in pregnancy in the Asia-Pacific region. , 2012, The Lancet. Infectious diseases.

[44]  O. Lund,et al.  Insight into Antigenic Diversity of VAR2CSA-DBL5 epsilon Domain from Multiple Plasmodium falciparum Placental Isolates , 2010 .

[45]  M. Molyneux,et al.  Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. , 2003, The American journal of tropical medicine and hygiene.

[46]  B. Brabin.  An analysis of malaria in pregnancy in Africa. , 1983, Bulletin of the World Health Organization.